PI News and Press, Impinj Inc. From 10/25/23

Impinj Inc. (PI) is expected to report $-0.56 for Q3 2023

2023-10-18 01:41:27 ET Summary Impinj has long-term opportunities to expand into more complex cases and other verticals, like the logistics market. The company faces risks such as timing on large deployments, inventory issues in the apparel industry, inflation, competition, and fi...

Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced that it will release financial results for its third-quarter ended September 30, 2023, after U.S. markets close on Wednesday, October 25, 2023. Impinj will host a conference call and webcas...

2023-10-05 08:05:19 ET Summary XSD is a broad and equal-weighted portfolio of US semiconductor stocks. The ETF has a consensus upside potential of 35% and weighted EPS growth of 45% and 53% for YE24 and YE25 respectively. XSD has outperformed the NASDAQ, making it a compelling...

2023-10-03 09:37:00 ET When most consumers think of the Internet of Things (IoT), a smart home speaker, a wearable device like a watch or earbuds, or some other type of equipment hooked up to a network may come to mind. But is that definition too narrow? Small IoT chip designer Impinj...

2023-07-31 07:50:51 ET Summary Impinj is touted for its fast growth and it is priced accordingly, but recent developments have shaken confidence in this belief. The latest guidance sees the top and the bottom line dropping due to inventories and soft demand, which runs counter to ...

2023-07-27 12:34:24 ET Shares of Impinj (NASDAQ: PI) , a maker of radio-frequency identification devices (RFID) and software to track them, tumbled 6.1% through 11:20 a.m. ET this morning despite edging out analyst expectations in its Q2 2023 earnings report last night. Heading ...

ATLANTA, July 27, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Impinj, Inc. (“Impinj” or the “Company”) (NASDAQ: PI) complied with federal securities laws.  On July 26, 2023, Impinj released its financial results for the second...

2023-07-27 08:38:02 ET Mersana Therapeutics ( MRSN ) -74% announces topline data from UPLIFT clinical trial in patients with platinum-resistant Ovarian Cancer and strategic reprioritization. Biohaven ( BHVN ) -27% . Yellow Corporation ( YELL ) -26% . ...

2023-07-27 06:28:15 ET Despite the Federal Reserve raising its policy rate to its highest level in 22 years, stock futures climbed in premarket trading on Thursday. Chair Jay Powell maintained his cautious tone in his news conference, but said that the Fed staff no longer f orecasts a U.S...